FDA provides preliminary approval for the drug filgotinib not approved, Galapagos will now assume full responsibility for filgotinib in Europe. Gilead will pay EUR 160 million to Galapagos to accelerate commercial activities in Europe. The gap from 19 march 2019 is filled....ready for the turn up..... what do you think?
Hi,
I'm seeing a nice possibility for some profits trading the Galapagos stock on the AEX. News announced just before the weekend about Gilead about acquiring Immunomedics, don't know how this would have a positive result on Galapagos but investors seem crazy.
There are 2 main resistance lines that are located around the 125,50 and 145,75. I would put a...
Galapagos NV is a European pharmaceutical research company
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful.
We can see that the stock is very oversold which could lead us to a good buying moment
We also see that it is respecting the resistance of 110.65 very well
We could place the SL at...
Galapagos left a big gap behind after tanking hard.
On the 1hr chart bullish divergence on the MACD and RSI has been formed and price is trying to break out of an ascending wedge.
Next thing I look at is the resistence from the 21 MA. If it can clear the MA and price finds support I will open a long position with big upside potential on closing the gap.
No...
I'm short right now, hoping to buy in the greenzone!
Keeping an eye on the resistance at EUR200.00, EUR183.00, EUR164.50
Following every Covid-19 news i can find..
My predictions tell me that the whitering of Galapagos will go further to a value between 170 and 160. This will happen in a time period of around 2 months. Same as it did in October when it had suffered a withering of around €30,- in a time period of 2,5 months.
It seems that after the price of Galapagos has reached the lowest point of 160 it will begin to grow...
We are currently in the middle of the month and Christmas is coming. This is a quiet period and normally there will be little movement here. We can therefore conclude that the biggest moves of the month have now come to an end within a week. Assuming that the price closes around this value at the end of the month, we see a pretty good respectation around 200. This...
Galapagos announced today a large investment and a 10-year deal with Gilead $GILD. The stock gapped due to Gilead buying 10% of Galapagos at $158/share. However, when stocks gap up on investments at a premium price, they almost always fall (see $MGI, $ARWR)
An analyst at Raymond James agrees, saying he believes $GLPG stock has now fully realized his price target...
